Amylyx Pharmaceuticals AMLX
NASDAQ AMLX
$27.79 -0.29 (-1.03%)
At close: Oct 2, 2026 · 4:00 PM EDT

Amylyx Pharmaceuticals (AMLX) Other Accumulated Expenses (2021 - 2022)

Updated

Amylyx Pharmaceuticals' Other Accumulated Expenses came in at $1.01 million for Q4 2022, up 289.5% from $258,000 a year earlier and up 182.3% from the prior quarter.

Analysis

Amylyx Pharmaceuticals (AMLX) Other Accumulated Expenses (2021 - 2022) Analysis & Trends

Going back to Q4 2021, Amylyx Pharmaceuticals' Other Accumulated Expenses data covers 5 quarters.

  • Going back by year, Other Accumulated Expenses was $258,000 in FY2021.
  • Business Quant data shows AMLX's Other Accumulated Expenses at $356,000 (Q3 2022), $535,000 (Q2 2022) and $439,000 (Q1 2022) in the three quarters before Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Amylyx Pharmaceuticals 3.09 Bn 3.09 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 1.01 Mn
Sep 30, 2022 356,000.00
Jun 30, 2022 535,000.00
Mar 31, 2022 439,000.00
Dec 31, 2021 258,000.00
API Access

Amylyx Pharmaceuticals Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=AMLX&period=max&api_key=YOUR_API_KEY